tirzepatide injections mesa for Weight Loss in Tirzepatide - Weightloss Medicine
Description
A retrospective cohort study of 128,453 Korean adult diabetic patients reported that thyroid cancer decreased significantly in metformin users compared to metformin nonusers [108]
Pea says when Metformin doesn't work, GLP-1s are a valid next step
doi: 10.1093/ibd/izae250 102 St-PierreJKleinJChoiNKFearEPannainSRubinDT
The mean time interval between surgery and the initiation of GLP-1RAs ranged from 1.5 to 87.6 months
TRIUMPH-1 extended the picture further: 28.3% at 80 weeks at the 12 mg dose, and 30.3% at 104 weeks in the extension group (participants with a BMI of 35 or higher a different subgroup, so the two figures are not a single continuous curve)
